FDAFDA · Food and drugs·Recall number D-1402-2012
Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0372-01
Published July 11, 2012 · Recall initiated: April 17, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LOXAPINE
- Manufacturer
- Watson Laboratories Inc
- Distributor
- Nationwide.
- UPC
- 0305910369019
- Lot
- Lot #s: 104432A, 104433A, 121344A, 127024A, 144290A
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.